AviadoBio’s Post

🌟 Exciting Announcement! I'm is thrilled to share that I will be participating in ESACT 24 in Edinburgh this week, you can find me at Cytiva's booth 72! 👩🔬 I'm excited to engage in discussions about the challenges facing the vaccine market. Together, we will explore strategies to make the vaccine process safer and more accessible to a larger number of patients, while maintaining regulatory requirements, patient safety, and risk mitigation. The vaccine market is constantly evolving, and it is crucial to find innovative solutions that address the complexities of vaccine development and distribution. By collaborating with experts and sharing insights at ESACT 24, we aim to drive positive change and shape the future of vaccines. If you are attending ESACT 24 or have a keen interest in discussing: - Cell line development for a more sustainable process - Process intensification for demanding risk mitigation - Close single-use System for patient safety please reach out. Let's work together to overcome these challenges and create a brighter future for healthcare. Looking forward to engaging conversations and productive discussions at ESACT 24! #ESACT24 #Biotechnology #VaccineInnovation #PatientSafety #RiskMitigation #RegulatoryCompliance #Cytiva

amnion backup leyton cells can be seen clearly

We’ve been talking for years about how the entire ecosystem will need to adjust when #CARTcellTherapy expands into expanded and larger patient populations. It shouldn’t be a surprise. I’m sure this will be a huge topic of discussion at #ATW24 . #celltherapy #genetherapy #apheresis #supplychain #logistics #cryopreservation #celltherapymanufacturing

Will suboptimal #referral for #CART #cartcelltherapy turnout to be it's Achilles heel? Beyond outpatient treatment what other approaches can alleviate capacity challenges at treatment centers? https://lnkd.in/dJg2xdD8

I don't know about you, but no matter what I do I cannot make my day have more than 24 hours, and I cannot make my week have more than 7 days. However......automation of boring & tedious data entry frees up HOURS! If you are an independent veterinary practice, you owe it to yourself and your team to take a look at what the combination of Covetrus Pulse and Zoetis Diagnostics can do for you. Let me know when we can schedule time together! #Veterinary #VetMed #VetTeam #Covetrus #Zoetis #TimeManagement #Diagnostics

Designing an Efficient, Predictable Global Post Approval Change System is presented by Anders Vinther as we move into afternoon concurrent sessions. He is presenting 8 specific and practical approaches to reduce the size of the PAC problem, which would facilitate less drug shortages and incentivize more continual improvement in the industry. #ISPE #ISPEEA24 #ISPEEuropeAnnual

Watching the "Hevolution" longevity conference... Great to finally see Longevity Science being FAAAR more mainstream than it was a few short years ago - including the participation of Big Pharma, starting with my former employer GSK (screenshot is from 1st day of conference): https://lnkd.in/gNEXxbpP When I worked at GSK in 2020, there didn't seem to be much general awareness about Longevity Science - until, in a surprise move, the CSO left the company to become CEO of Altos Lab (a fascinating "turning point in history" that I discuss in this article: https://lnkd.in/gXYNuGjM ) Also participating in the Hevolution conference was Andrew Adams , a SVP from Lilly (timeline 5:21:23 in the above video) An inspiring conference. And a lot of forthcoming funds for research, courtesy of the Saudis! 😊 #longevity #healthspan #conference2023 #Hevolution #aging #medicine

Please reach out to see how this can help you with your testing needs!

The collaborative mission of HESI's #TPDS committee is to advance efficient and effective translational safety assessment to maximize the therapeutic potential of targeted protein degraders for patients by an international network of multi-partite, multi-stakeholder experts. Check out their 2023 highlights and what they are focusing on in 2024. https://lnkd.in/gQ4ziG9P